Post-infectious irritable bowel syndrome after a laboratory-proven enteritis

被引:11
|
作者
Iacob, Teodora [1 ]
Tatulescu, Doina F. [1 ]
Lupse, Mihaela S. [1 ]
Dumitrascu, Dan L. [2 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Dept Infect Dis, Cluj Napoca 400348, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Med Dept 2, 3-6 Clinicilor St, Cluj Napoca 400006, Romania
关键词
post-infectious irritable bowel syndrome; acute infectious gastroenteritis; laboratory; microbiology; coproparasitological examination; enzyme-linked fluorescent assay; CLOSTRIDIUM-DIFFICILE INFECTION; BACTERIAL GASTROENTERITIS; RISK-FACTORS; PREVALENCE; OUTBREAK; DIARRHEA; EPIDEMIOLOGY; PROBIOTICS; DISORDERS; DYSPEPSIA;
D O I
10.3892/etm.2020.9018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There are scarce data on risk factors for post-infectious irritable bowel syndrome (PI-IBS). The objective of this study was to determine the risk factors of developing PI-IBS following an acute infectious gastroenteritis (AGE) episode in which, by laboratory tests, the etiological agent was isolated. The study was conducted on patients admitted to a tertiary center of infectious diseases during three consecutive years. The patients were divided into two groups: a group consisting of patients admitted with AGE (with an isolated etiological agent) and a control group consisting of patients admitted for an acute upper respiratory tract infection (URTI). The subjects were recalled in our center 6 months after the admission and were evaluated with Rome III IBS diagnostic questionnaire and Bristol Stool Form Scale. The questionnaires were paper printed and directly filled in by the subjects. The response rate in the case group was 5% and in the control group 100%. The prevalence of PI-IBS was higher in patients with AGE, presenting a relative risk (RR) of 4.16 [95% confidence interval (CI), 1.89-9.17], statistically significant (P<0.001) vs. URTI. From 28 female patients, 22 patients (79%) developed PI-IBS and from 17 male patients, 3 patients (18%) had developed PI-IBS with a risk of 4.4 (95% CI, 1.56-12.65), P<0.001. Regarding the infectious etiology of the AGE, Campylobacter jejuni had the highest risk of developing PI-IBS, RR=1.2 (95% CI, 0.13-3.11), P=0.04 compared with the other agents with a lower risk. The risk to develop PI-IBS after AGE infection is 4.16 higher than after URTI. Female sex is a risk factor for PI-IBS, 79% of the female patients developed PI-IBS after AGE. The incidence of PI-IBS is highest in patients with Campylobacter jejuni AGE compared with the other agents.
引用
收藏
页码:3517 / 3522
页数:6
相关论文
共 50 条
  • [41] AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms
    Meynier, Maeva
    Baudu, Elodie
    Rolhion, Nathalie
    Defaye, Manon
    Straube, Marjolene
    Daugey, Valentine
    Modoux, Morgane
    Wawrzyniak, Ivan
    Delbac, Frederic
    Villeger, Romain
    Meleine, Mathieu
    Nogues, Esther Borras
    Godfraind, Catherine
    Barnich, Nicolas
    Ardid, Denis
    Poirier, Philippe
    Sokol, Harry
    Chatel, Jean-Marc
    Langella, Philippe
    Livrelli, Valerie
    Bonnet, Mathilde
    Carvalho, Frederic Antonio
    GUT MICROBES, 2022, 14 (01)
  • [42] Montezuma's revenge-the sequel: The one-hundred year anniversary of the first description of “post-infectious” irritable bowel syndrome
    Mark S Riddle
    Patrick Connor
    Chad K Porter
    World Journal of Gastroenterology, 2018, (45) : 5076 - 5080
  • [43] Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats
    Zhou, Hui-hui
    Zhang, Ye-ming
    Zhang, Sheng-peng
    Xu, Qi-xiang
    Tian, Ya-qing
    Li, Ping
    Cao, Di
    Zheng, Yong-qiu
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT
    Austhof, Erika
    Bell, Melanie L.
    Riddle, Mark S.
    Catalfamo, Collin
    McFadden, Caitlyn
    Cooper, Kerry
    Walter, Elaine Scallan
    Jacobs, Elizabeth
    Pogreba-Brown, Kristen
    EPIDEMIOLOGY AND INFECTION, 2022, 150
  • [45] Long-term Clinical Course of Post-infectious Irritable Bowel Syndrome After Shigellosis: A 10-year Follow-up Study
    Youn, Young Hoon
    Kim, Hyeon Chang
    Lim, Hyun Chul
    Park, Jae Jun
    Kim, Jie-Hyun
    Park, Hyojin
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (03) : 490 - 496
  • [46] Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice
    Lijun Du
    Yanqin Long
    John J. Kim
    Binrui Chen
    Yubin Zhu
    Ning Dai
    Digestive Diseases and Sciences, 2019, 64 : 729 - 739
  • [47] Montezuma's revenge - the sequel: The one-hundred year anniversary of the first description of "post-infectious" irritable bowel syndrome
    Riddle, Mark S.
    Connor, Patrick
    Porter, Chad K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (45) : 5076 - 5080
  • [48] Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice
    Du, Lijun
    Long, Yanqin
    Kim, John J.
    Chen, Binrui
    Zhu, Yubin
    Dai, Ning
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (03) : 729 - 739
  • [49] Is irritable bowel syndrome an infectious disease?
    Thompson, John Richard
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (04) : 1331 - 1334
  • [50] Is irritable bowel syndrome an infectious disease?
    John Richard Thompson
    World Journal of Gastroenterology, 2016, (04) : 1331 - 1334